Mild to moderate asthmatic children treated at two primary care settings Childhood Asthma, Clinical Outcomes, Effectiveness, Lycopene-rich diet, Pulmonary Function Test
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: asthmatic children aged 4-15 years who were physician diagnosed, mildly or moderately persistent asthma following the Global Initiative for Asthma guidelines , previously treated and ICS prescribed within 24 months, comply with blood test and pulmonary function test, and completed follow-up for the 8-week period.
Exclusion criteria
Exclusion criteria: prior airway infection within 4 weeks, previous acute asthmatic exacerbation within 3 months, had chronic diseases such as cardiovascular, pulmonary, neurology, renal, or psychiatric conditions, prior consumed high dose of supplemental diet such as lycopene (60 mg/day), beta-carotene (30 mg/day) or ascorbic acid (180 mg/day) within 3 months , who denied tomato with mixed fruits juice consumption, or lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| asthmatic clinical control at 8 weeks after initiation of the intervention asthma control test score | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life, pulmonary function, antioxidant serum level at 8 weeks after initiation of intervention Pediatric Asthma Quality of Life Questionnaire, FEV1,FEV1/FVC, FE25-75%, level of serum antioxidants | — |
Countries
Thailand
Contacts
Faculty of Medicine, King Mongkut's Institute of Technology at Ladkrabang at